How to inject tirzepatide at home: a practical guide

Choosing where to inject, and why rotation matters more than most people think

One of the most common misconceptions is that injecting in the same spot each week is fine because it hurts less. It is not. Repeatedly using the same small area can cause lipohypertrophy, a build-up of fatty tissue under the skin that affects how reliably the medicine absorbs. Rotating within a site (choosing a different patch of abdomen, not the same centimetre) and swapping between sites week to week protects against this.

The three licensed sites for tirzepatide injection are the lower abdomen (avoiding a two-inch radius around the navel), the front or outer thigh, and the upper outer arm. The abdomen tends to give the most consistent absorption for most people and is the easiest to reach solo. The upper arm is perfectly valid but usually needs a second person or a firm surface to stabilise.

Avoid skin that is bruised, tender, scarred, or has a rash. Clean the area with an alcohol swab and let it dry fully before injecting, wet skin stings more and the alcohol can interfere with the skin surface. Medical-grade alcohol swabs are the standard tool for this step. A moment's patience here makes a real difference.

The injection itself: what to do at each stage

Remove the pen from the fridge about 30 minutes before use. A cold pen is more likely to sting. Check the solution through the viewing window, it should be clear or slightly yellow, with no floating particles. If it looks cloudy or contains visible matter, do not use it and contact your pharmacy.

Pinch a fold of skin gently between thumb and forefinger. Hold the KwikPen firmly against the skin, press the button, and keep the pen in place until the injection indicator confirms completion, usually a few seconds. Releasing too early is the single most common cause of an incomplete dose. Release the pinch, withdraw the pen, and apply gentle pressure with a clean finger if there is any bleeding. Do not rub.

For full step-by-step guidance with the KwikPen, the tirzepatide injection technique page covers each stage in detail, and the Patient Information Leaflet inside your pack is the definitive reference from Eli Lilly.

Storing your pen before and after use, and disposing of it safely

Tirzepatide pens are stored in the fridge between 2°C and 8°C. Each pen delivers four weekly doses, so it goes back into the fridge after each use. There is a limited window during which an in-use pen can be kept at room temperature, the exact duration is specified in the Patient Information Leaflet and varies by how the pen is being used, so always check your leaflet rather than relying on a figure quoted online. General Mounjaro storage guidance covers the key rules in plain language.

Once the pen is empty, it becomes a clinical sharp. Place it directly into a rigid, puncture-resistant sharps container, the yellow lidded type. Many community pharmacies and GP surgeries run free sharps collection. A 1-litre sharps container holds several months of used pens and meets NHS disposal requirements. Never put a used pen in the kitchen bin.

On timing your weekly dose: you can choose any day that fits your routine, the important thing is keeping roughly the same 7-day gap each time. The NHS tirzepatide medicines page has patient-level information on missed doses and what to do if you are more than a day late; always follow that guidance or contact your prescriber.

When to get medical help, and how to report concerns

Most people experience some nausea after starting or increasing their dose, particularly in the first week or two. This is expected and generally settles. Staying well hydrated and eating smaller, lower-fat meals during this period helps considerably.

Seek urgent medical attention if you develop severe, persistent abdominal pain that radiates to your back, with or without vomiting. This can be a sign of pancreatitis, and in January 2026 the MHRA issued a Drug Safety Update specifically highlighting this risk with GLP-1 receptor agonist medicines. Other symptoms needing prompt attention include signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing), significant dehydration from vomiting or diarrhoea, or any unusual changes that concern you. The MHRA Yellow Card scheme lets patients report suspected side effects directly, and doing so helps improve safety monitoring for everyone using these medicines.

The NHS tirzepatide page lists the full side-effect profile and is the clearest patient-level resource available. If you have any doubt about a symptom, contact your prescriber or call 111. Our aftercare team is available seven days a week for patients treating with nume.

If you are considering starting treatment and want to understand what clinical assessment involves, starting your free consultation is the first step. A GPhC-registered prescriber reads every application personally before any prescription is issued.